The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Open accessAbstract
A growing body of evidence indicates that resolution of acute inflammation is an active process. Resolvins are a new family of lipid mediators enzymatically generated within resolution networks that possess unique and specific functions to orchestrate catabasis, the phase in which disease declines. Resolvin D2 (RvD2) was originally identified in resolving exudates, yet its individual contribution in resolution remained to be elucidated. Here, we establish RvD2's potent stereoselective actions in reducing excessive neutrophil trafficking to inflammatory loci. RvD2 decreased leukocyte-endothelial interactions in vivo by endothelial-dependent nitric oxide production, and by direct modulation of leukocyte adhesion receptor expression. In mice with microbial sepsis initiated by caecal ligation and puncture, RvD2 sharply decreased both local and systemic bacterial burden, excessive cytokine production and neutrophil recruitment, while increasing peritoneal mononuclear cells and macrophage phagocytosis. These multi-level pro-resolving actions of RvD2 translate to increased survival from sepsis induced by caecal ligation and puncture and surgery. Together, these results identify RvD2 as a potent endogenous regulator of excessive inflammatory responses that acts via multiple cellular targets to stimulate resolution and preserve immune vigilance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From a translational perspective, SPMs suppress inflammation but, unlike anti-inflammatory drugs, these pro-resolving mediators promote both repair and continued pathogen clearance33,213–215.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [215]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,134
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,036
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Self-citationImmunodesign of experimental sepsis by cecal ligation and puncture
Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., & Ward, P. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.214 · Cited by 2,209
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationDombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,253
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Self-citationThe discovery of nitric oxide and its role in vascular biology
Moncada, S., & Higgs, E. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706458 · Cited by 863
Animal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. V. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 838
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 694
Molecular Circuits of Resolution in Airway Inflammation
Carlo, T., & Levy, B. D. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.143 · Cited by 11
Pathways involved in the resolution of inflammatory joint disease
Haworth, O., & Buckley, C. D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.04.002 · Cited by 13
Zaitone, S. A., Moustafa, Y. M., Mosaad, S. M., & El-Orabi, N. F. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31821c8353 · Cited by 12
Beyond cardiovascular medicine: potential future uses of icosapent ethyl
Bhatt, D. L., Hull, M. A., Song, M., Hulle, C. V., Carlsson, C. M., Chapman, M. J., & Toth, P. P. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa119 · Cited by 14
Beegun, I., Koenis, D. S., Alusi, G., & Dalli, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733019 · Cited by 12
Lagarde, M. (2010) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201000045 · Cited by 12
Specialized pro‐resolving mediators: wiring the circuitry of effector immune and tissue homeostasis
Fredman, G., & Serhan, C. N. (2011) · Endodontic Topics · doi:10.1111/etp.12010 · Cited by 12
Self-citationLi, S.-J., He, X.-L., Zhang, X., Li, Z.-R., Liu, H.-L., Zhang, Y., Lu, M.-Q., Chen, J., Dong, X.-M., Long, W., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108109 · Cited by 16
Exploring the unique role of specialized pro-resolving mediators in cancer therapeutics
Quinlivan, K. M., Howard, I. V., Southan, F., Bayer, R. L., Torres, K. L., Serhan, C. N., & Panigrahy, D. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106944 · Cited by 12
Self-citationGüler, A. A., Rossi, F. W., Bellando-Randone, S., Prevete, N., Tufan, A., Manetti, M., de Paulis, A., & Matucci‐Cerinic, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01249 · Cited by 14
The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis
Nienaber, A., Hayford, F. E. A., Variava, E., Martinson, N. A., & Malan, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.623941 · Cited by 12
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4_3 · Cited by 11
Warming to 39°C but Not to 37°C Ameliorates the Effects on the Monocyte Response by Hypothermia
Billeter, A. T., Rice, J., Druen, D., Sklare, S., Walker, S., Gardner, S. A., & Polk, H. C. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001175 · Cited by 11
Specialized pro-resolving mediators: Biosynthetic pathways, biocatalytic synthesis, and applications
Lee, T., Shin, K., Park, J., & Oh, D. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108682 · Cited by 10
Aznar, A. G., Egea, F. M., Banzo, R. G., Gutiérrez, R., Rizo, J. M., Ledo, P. R., Nerín, I., & Regidor, P. (2024) · Biomedicines · doi:10.3390/biomedicines12102221 · Cited by 10
Shin, K., Lee, T., Kim, S., Ko, Y., Seo, M., & Oh, D. (2022) · Catalysts · doi:10.3390/catal12101145 · Cited by 10
Fish oil-containing lipid emulsions in patients with sepsis
Mayer, K., & Seeger, W. (2010) · Critical Care · doi:10.1186/cc8882 · Cited by 9
THE INHIBITORY EFFECT OF GALANGIN ON CYTOKINES AND NITRIC OXIDE IN MICROGLIA BV2 CELL LINE
Al-Abd, N., Kassim, M., & Zajmi, A. (2017) · Malaysian Journal of Science · doi:10.22452/mjs.vol36no3.2 · Cited by 11
Silva, J. B. N. F., Calcia, T. B. B., Silva, C. P., Guilherme, R. F., Almeida-Souza, F., Lemos, F. S., Calabrese, K. D. S., Caruso‐Neves, C., Neves, J. S., & Benjamim, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111634 · Cited by 10
Ramirez, J. L., Zahner, G. J., Spaulding, K. A., Khetani, S. A., Hills, N. K., Gasper, W. J., Harris, W. S., Cohen, B. E., & Grenon, S. M. (2019) · Lipids · doi:10.1002/lipd.12140 · Cited by 10
Interface between Resolvins and Efferocytosis in Health and Disease
Mohammad‐Rafiei, F., Negahdari, S., Tahershamsi, Z., & Hayat, S. M. G. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01187-4 · Cited by 8
The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum malaria in children
Surowiec, I., Gouveia-Figueira, S. C., Orikiiriza, J., Lindquist, E., Bonde, M., Magambo, J., Muhinda, C., Bergström, S., Normark, J., & Trygg, J. (2017) · Malaria Journal · doi:10.1186/s12936-017-2001-y · Cited by 8
The Resolution Approach to Cystic Fibrosis Inflammation
Recchiuti, A., Patruno, S., Plebani, R., & Romano, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01129 · Cited by 9
Reinertsen, A. F., Primdahl, K. G., Matteis, R. D., Dalli, J., & Hansen, T. V. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202103857 · Cited by 9
Levy, E. S., Kim, A. S., Werlin, E. C., Chen, M., Sansbury, B. E., Spite, M. R., Desai, T. A., & Conte, M. S. (2023) · JVS Vascular Science · doi:10.1016/j.jvssci.2023.100126 · Cited by 9
Self-citationStereocontrolled synthesis of resolvin D1
Morita, M., Wu, S., & Kobayashi, Y. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob03128b · Cited by 9
Panchalingam, S., & Govindaraju, K. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108452 · Cited by 8
HS1 deficiency protects against sepsis by attenuating neutrophil-inflicted lung damage
Guerrero-Fonseca, I. M., García‐Ponce, A., Vadillo, E., Lartey, N. L., Vargas‐Robles, H., Chánez-Paredes, S. D., Castellanos-Martínez, R., Nava, P., Betanzos, A., Neumann, B. M., et al. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151214 · Cited by 9
Major Structure–Activity Relationships of Resolvins, Protectins, Maresins and Their Analogues
Daly, K., O'Sullivan, K., & O’Sullivan, T. P. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0206 · Cited by 8
Dyke, T. E. V. (2012) · PubMed · Cited by 8
Dysregulation of lipid mediators in patients with frequent exacerbations of COPD
Fisk, M., Gómez, E. A., Sun, Y., Mickute, M., McEniery, C. M., Cockcroft, J., Bolton, C. E., Fuld, J. P., Cheriyan, J., Yasmin, W. M., et al. (2025) · ERJ Open Research · doi:10.1183/23120541.00950-2023 · Cited by 8
Reframing chronic wound therapy: from growth factor delivery to regenerative immuno-engineering
Wang, Z., Zeng, X., Feng, W., Lu, Y., & Wei, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1683591 · Cited by 8
Tatsuno, I. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.971756 · Cited by 7
Wang, C., Sun, C., Ding, Z., Wu, X., Liu, K., & Cao, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s493987 · Cited by 8
Potential of specialized pro-resolving lipid mediators against rheumatic diseases
Murakami, K. (2016) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.39.155 · Cited by 7
Adjunctive treatment in septic shock: What's next?
Annane, D. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.03.004 · Cited by 7
The Potential of Fish Oil Components and Manuka Honey in Tackling Chronic Wound Treatment
Clare, J., Lindley, M. R., & Ratcliffe, E. (2024) · Microorganisms · doi:10.3390/microorganisms12081593 · Cited by 6
Leukotriene B4 receptor 1 (BLT1) activation by leukotriene B4 (LTB4) and E resolvins (RvE1 and RvE2)
Nunes, V. S., Rogério, A. D. P., Abrahão, O., & Serhan, C. N. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108236 · Cited by 6
Self-citationResolvin D2-induced reparative dentin and pulp stem cells after pulpotomy in a rat model
Yoneda, M., Ideguchi, H., Nakamura, S., Arias, Z., Ono, M., Omori, K., Yamamoto, T., & Takashiba, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34206 · Cited by 6
Resolvin D4 mitigates lipopolysaccharide-induced lung injury in mice
Inomata, R., Tsubouchi, H., Takao, T., Kurokawa, M., Yanagi, S., Sakai, K., & Miyazaki, T. (2024) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2024.102652 · Cited by 6
Thornton, J. M., Padovani, C. M., Rodrı́guez, A. R., Spur, B. W., & Yin, K. (2023) · The FASEB Journal · doi:10.1096/fj.202300619r · Cited by 5
Resolvins, protectins and other lipid mediators in obesity-associated inflammatory disorders
Clària, J., Titos, E., López‐Vicario, C., & González‐Périz, A. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.10.002 · Cited by 8
Kanamori, S., Ishida, H., Yamamoto, K., & Itoh, T. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.07.004 · Cited by 6
Apoptosis and Efferocytosis in Inflammatory Diseases
Purnama, C. A., Meiliana, A., Barliana, M. I., Dandan, K. L., & Wijaya, A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i3.1608 · Cited by 5
Lipidmediatoren und ihre Rolle bei Entzündungen und Allergien
Stockert, K. (2020) · Springer eBooks · doi:10.1007/978-3-662-58140-7_6 · Cited by 6
Die Rolle neuer „pro-resolving” Lipidmediatoren bei entzündlichen Lungenerkrankungen
Eickmeier, O., Hilberath, J. N., Zielen, S., & Haworth, O. (2010) · Pneumologie · doi:10.1055/s-0030-1255913 · Cited by 7
Zhao, D., Yang, B. K., Ye, C., Zhang, S., Lv, X., & Chen, Q. (2021) · Innate Immunity · doi:10.1177/17534259211057038 · Cited by 5
Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend
Rahman, M. S., & Hossain, M. S. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00919-4 · Cited by 5
Lee, T., Ko, Y., Shin, K., & Oh, D. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04032-9 · Cited by 6
Wei, J.-X., Mo, H., Zhang, Y., Deng, W., Zheng, S., Mao, H., Ji, Y., Jiang, H., & Zhu, Y. (2024) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2024.083 · Cited by 5
Proresolving mediators: new therapies to treat inflammatory diseases
Stopka‐Farooqui, U., & Haworth, O. (2015) · Clinical Lipidology · doi:10.2217/clp.15.19 · Cited by 5
Lipid Mediators and Lung Function
Weinberger, B. I., Hirsch, D. S., Yin, K., & Spur, B. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-404577-4.00021-7 · Cited by 5
Molecular mechanisms underlying effects of n−3 and n−6 fatty acids in cardiovascular diseases
Kollareth, D. J. M., Chang, C. L., Zirpoli, H., & Deckelbaum, R. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00021-x · Cited by 5
Elhameed, A. G. A. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-11921-7 · Cited by 6
Botten, N., Hodges, R. R., Bair, J. A., Utheim, T. P., Serhan, C. N., Yang, M., & Dartt, D. A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30854 · Cited by 5
Self-citationDe-Oliveira, R. B. B., Kato, E. E., de Lima, T. S., Alba‐Loureiro, T. C., Curi, R., Cirillo, M. C., & Sampaio, S. C. (2018) · Preprints.org · doi:10.20944/preprints201805.0322.v1 · Cited by 4
The Resolvin D2-GPR18 Axis Enhances Bone Marrow Function and Limits Hepatic Fibrosis in AgingPreprint
Fitzgerald, H., Bonin, J. L., Sadhu, S., Lipscomb, M., Biswas, N., Decker, C., Nabage, M., Bossardi, R., Marinello, M., Mena, H. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.05.522881 · Cited by 5
Self-citationPinto, I. C., Saito, P., Rodrigues, C. C. A., Martinez, R. M., Melo, C. P. B., Piva, M., Kumagai, C. M., do Vale, D. L., Saraiva‐Santos, T., Bussmann, A. J. C., et al. (2025) · Antioxidants · doi:10.3390/antiox14070830 · Cited by 4
Nouveau benzo-mimetics of 17R-Resolvin D2 are potent resolution agonists for inflammation
Serhan, C. N., Chiang, N., Simard, M., Nshimiyimana, R., Rodrı́guez, A. R., Mun, S. J., Irimia, D., & Spur, B. W. (2025) · iScience · doi:10.1016/j.isci.2025.114201 · Cited by 4
Self-citationMemida, T., Cao, G., Abdolahinia, E. D., Ruiz, S., Huang, S., Hassantash, S., Shindo, S., Okamoto, M., Yamashita, S., Nakamura, S., et al. (2025) · Cells · doi:10.3390/cells14120860 · Cited by 4
Brüggemann, T. R., Tavares, L. P., Almanzar, N., Singh, D., Batchelder, H., Nshimiyimana, R., Haber, A. L., Demokritou, P., Serhan, C. N., & Levy, B. D. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.08.014 · Cited by 4
Self-citationSupplementation with GPR120 (Ffar4) ligand omega-3 does not improve survival in murine sepsis models
Nakandakari, S. C. B. R., Elliott, E. I., Vieira, R. F. L., Rios, T. D. S., Fosam, A. E., Pavan, I. C. B., Costa, M. M., da Silva, L. G. S., Ramos, C. D. O., Gonçalves, G. R., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00147.2025 · Cited by 4
Emerging role of cell membrane-coated nanoparticles in targeted therapy for brain disorders
Kumari, V., Shahrukh, M., Jabin, K., Ali, N., Hasan, N., Aqil, M., & Ahmad, F. J. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214822 · Cited by 4
The urinary lipid profile in cats with idiopathic cystitis
Takenouchi, S., Kobayashi, Y., SHINOZAKI, T., Kobayashi, K., Nakamura, T., Yonezawa, T., & Murata, T. (2022) · Journal of Veterinary Medical Science · doi:10.1292/jvms.22-0049 · Cited by 4
Vagus nerve stimulation: Potential for treating chronic wounds
Budhiraja, A., Mehta, A., Alhamo, M. A., Swedarsky, R., Dahle, S. E., & Isseroff, R. R. (2024) · Wound Repair and Regeneration · doi:10.1111/wrr.13151 · Cited by 4
Ringheim-Bakka, T. A., Saliani, A., Østbye, T.-K. K., Mildenberger, J., Dooley, M., Busygina, M., Pedersen, M. E., Solberg, N. T., Dalli, J., & Gammelsæter, R. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101016 · Cited by 4
Papel dos ácidos graxos ômega 3 na resolução dos processos inflamatórios
Barbalho, S. M., Bechara, M. D., Quesada, K. R., & Goulart, R. A. (2011) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v44i3p234-240 · Cited by 4
Lipoxins, Resolvins, and the Resolution of Inflammation
Recchiuti, A., Cianci, E., Simiele, F., & Romano, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27766-0_10 · Cited by 4
Endogenous Anti-inflammatory and Proresolving Lipid Mediators in Renal Disease
Serhan, C. N., & Godson, C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380928-5.10004-1 · Cited by 5
Self-citationEffects of Nutrition on Neutrophil Function in Preclinical Studies
Kohama, K., Kotani, J., & Nakao, A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8503-2_144-1 · Cited by 6
Recchiuti, A., Federti, E., Mattè, A., Mazzi, F., Ceolan, J., Porreca, A., Nicola, M. D., Menotti, S., Alivernini, S., & Franceschi, L. D. (2022) · American Journal of Hematology · doi:10.1002/ajh.26797 · Cited by 4
Alleviative Effect of Geniposide on Lipopolysaccharide-Stimulated Macrophages via Calcium Pathway
Kim, H.-J., & Park, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031728 · Cited by 4
Cai, N., Gao, X. S., Jia, L., Liu, Y., Zhou, L., Zhao, J., Qü, J., & Zhou, Y. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107805 · Cited by 4
The Impact of Macrophage Membrane Lipid Composition on Innate Immune Response Mechanisms
Schumann, J. E. (2012) · InTech eBooks · doi:10.5772/25297 · Cited by 4
Abumrad, N. A., Piomelli, D., Yurko‐Mauro, K., Merrill, A. H., Clandinin, M. T., & Serhan, C. N. (2012) · Advances in Nutrition · doi:10.3945/an.111.000802 · Cited by 4
Self-citationOral omega-3 fatty acids promote resolution in chemical peritonitis
Chacon, A. C., Phillips, B. E., Chacon, M. A., Brunke-Reese, D., Kelleher, S. L., & Soybel, D. I. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.06.036 · Cited by 4
Mechanisms and Consequences of Intestinal Inflammation
McKay, D. M., & MacNaughton, W. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00078-6 · Cited by 5
Das, U. N. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001793 · Cited by 4
Cai, N., Gao, X. S., Jia, L., Liu, Y., Zhao, J., Qü, J., & Zhou, Y. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108050 · Cited by 3
Macrophages and the Entrance of Resolution Phase Lipid Mediators
Serhan, C. N., Chiang, N., & Dalli, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_13 · Cited by 3
Self-citationWang, L., Choi, H. S., Su, Y., Lee, B., Choi, J. H., Jang, S., Jang, Y., & Seo, J. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12794 · Cited by 3
The Mucosal Immune System and Gastrointestinal Inflammation
Cominelli, F., Arseneau, K. O., Blumberg, R. S., Stenson, W. F., & Pizarro, T. T. (2008) · Wiley eBooks · doi:10.1002/9781444303254.ch7 · Cited by 3
Moudt, S. D., Sitek, B., Bar, A., Lourenco‐Rodrigues, M., Lagrange, J., Yen, F. T., Chłopicki, S., Mercier, N., & Bäck, M. (2025) · The FASEB Journal · doi:10.1096/fj.202503386r · Cited by 2
Progress on Omega-3 fatty acids for the comprehensive and targeted treatment of spinal cord injury
Yuan, Z., Shi, L., Tao, X.-N., Fan, X., Zheng, H., Shang, Y., Zhao, X., Yang, F., Lin, H. X., Xiao, P., et al. (2026) · Bone Research · doi:10.1038/s41413-025-00461-w · Cited by 4
Schober, M. E., Terry, C. R., Monts, J. K., Jones, G. C., Ritzel, R. M., & Loane, D. J. (2026) · Journal of Neurotrauma · doi:10.1177/08977151251393989 · Cited by 2
Lu, X., Rehman, H., & Markworth, J. F. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_344 · Cited by 2
Liu, X. G., Ma, L., Fan, Z., Fan, J., Lu, W., Zhang, L., & Li, J. (2026) · Food & Function · doi:10.1039/d6fo01257d · Cited by 2
Nazemidashtarjandi, S., Supple, M., Yonker, L. M., Sheridan, R. L., Ryan, C. M., Karabacak, M., Goverman, J. M., Yarmush, M. L., & Irimia, D. (2025) · The FASEB Journal · doi:10.1096/fj.202402018r · Cited by 2
224 Characterization of a novel rat model of W1098X CFTR generated by Crispr-Cas9
Allen, A. D., Stanford, D. D., Rasmussen, L. W., Antony, L., Challa, A. K., & Raju, S. (2023) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(23)01154-2 · Cited by 2
Sabatino, A., & Fiaccadori, E. (2015) · Springer eBooks · doi:10.1007/978-1-4614-7836-2_87 · Cited by 2
Koutsostathis, S. D., Τσαγανός, Θ., Giamarellos‐Bourboulis, E. J., Kotsaki, A., Papalois, A. E., & Efstathopoulos, N. E. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.05.001 · Cited by 2
Adadey, S. M., Yakass, M. B., Agyemang, S., & Duodu, S. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163815666180227162926 · Cited by 2
(2018) · Pediatric Pulmonology · doi:10.1002/ppul.24151 · Cited by 1
Cecconello, C., Claria-Ribas, P., & Norling, L. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822130-3.00018-1 · Cited by 2
Self-citationChoi, M. Y., Cook, N. R., Kotler, G., Serhan, C. N., Tatituri, R. V. V., & Costenbader, K. H. (2022) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/xxr27t · Cited by 2
Self-citationSong, Y.-K., Lee, J.-Y., & Park, W. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/1894837 · Cited by 2
Strategies for the Synthesis of Anti-inflammatory Metabolites of Unsaturated Fatty Acids
Kobayashi, Y., & Morita, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-6244-6_9 · Cited by 3
The effects of resolvins on dermal wound healing
Menon, R. (2012) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3639np7 · Cited by 2
Erdman, L. K. (2012) · TSpace (University of Toronto) · Cited by 2
Resolvin D2-GPR18 Signaling on Myeloid Cells Limits Plaque NecrosisPreprint
Lipscomb, M., Walis, S., Marinello, M., Mena, H. A., Spite, M. R., & Fredman, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.03.535493 · Cited by 2
Self-citation
Metadata
- Authors
- Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Queen Mary University of London (GB)
- University of Southern California (US)
- Corresponding author
- Serhan, Charles N.
- ORCID
- Venue
- Nature
- Published
- 2009-10
- Volume
- 461
- Issue
- 7268
- Pages
- 1287-1291
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2779525
- OpenAlex
- W1974226247
- Cited by
- 695
- References
- 33
- Citations by year
- 2026: 21 · 2025: 19 · 2024: 35 · 2023: 34 · 2022: 42 · 2021: 49 · 2020: 61 · 2019: 40 · 2018: 40 · 2017: 44 · 2016: 54 · 2015: 45 · 2014: 39 · 2013: 50 · 2012: 48
- FWCI
- 38.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Funders
- Wellcome Trust (086867/Z/08/Z, 085903/Z/08)
- Versus Arthritis (18445, 18103)
- National Institutes of Health (4r37gm038765-19)
- National Heart, Lung, and Blood Institute (HL087526, F32HL087526)
- National Institute of General Medical Sciences (GM 38765, R01GM038765, R37-GM038765)
- National Institute of Dental and Craniofacial Research (P50DE016191)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- resolvin D2, inflammation resolution, neutrophil trafficking, leukocyte-endothelium interaction, nitric oxide, leukocyte adhesion molecules, cecal ligation and puncture, bacterial load, macrophage phagocytosis, anti-inflammatory agents, host defense
- MeSH terms
- Animals, Docosahexaenoic Acids, Escherichia coli, Humans, Inflammation, Leukocytes, Macrophages, Male, Mice, Inbred C57BL, Nitric Oxide, Peritoneal Cavity, Peritonitis, Phagocytosis, Reactive Oxygen Species, Sepsis, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
